Plasma interferon-gamma-inducible protein 10 can be used to predict viral load in HIV-1-infected individuals

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 3, 2013, Pages

  Gray, Clive M ^a,b   Hong, Heather A ^c,d   Young, Katherine ^a   Lewis, David A ^c,d   Fallows, Dorothy ^e   Manca, Claudia ^e   Kaplan, Gilla ^e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; VIRUS RNA;

CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; COLORIMETRY; DIAGNOSTIC KIT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; GENITAL SYSTEM; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; LETTER; LEUKOCYTE; LIVER FIBROSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLIC HEALTH; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

BIOLOGICAL MARKERS; CHEMOKINE CXCL10; HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD;

EID: 84880236199     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182930ea8     Document Type: Letter

References (9)

1. Kaplan G, Luster AD, Hancock G, et al. The expression of gamma interferon-induced protein (IP10) in delayed immune responses in human skin. J Environ Monit. 1987;166: 1098-1108.
2. Liovat AS, Rey-Cuille MA, Lecuroux C, et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One. 2012;7:e46143.
3. Grebely J, Feld JJ, Applegate T, et al. Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology. 2013. doi: 10.1002/hep.26263.
4. Cinque P, Bestetti A, Marenzi R, et al. Cerebro-spinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J Neu-roimmunol. 2005;168:154-163.
5. Jiao Y, Zhang T, Wang R, et al. Plasma IP-10 is associated with rapid disease progression in early HIV-1 infection. Viral Immunol. 2012; 25:333-337.
6. Blish CA, McClelland RS, Richardson BA, et al. Genital inflammation predicts HIV-1 shedding independent of plasma viral load and systemic inflammation. J Acquir Immune Defic Syndr. 2012;61:436-440.
7. Carsenti-Dellamonica H, Saidi H, Ticchioni M, et al. The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up. HIV Med. 2011; 12:65-77.
8. Riou C, Perez Peixoto B, Roberts L, et al. Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis. PLoS One. 2012;7: e36886.
9. Zeremski M, Markatou M, Brown QB, et al. Inter-feron gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients. J Acquir Immune Defic Syndr. 2007;45:262-268.